2026| 2025 | 2024

2025

January 27^th – 30^th, 2025

Jenny, Irene and Finn had the honor of attending The University of Nairobi STD/HIV/SRI Collaborative Research Group Annual Review Meeting in Kenya. 

Irene presented her work “Menstrual Phase-Dependent T Cell Phenotypic Changes in the female Genital Tract and Circulation: Implications for Vulnerability to Sexually Transmitted Infections”

Finn presented his work “Expanding the immunological hypothesis for increased HIV susceptibility associated with bacterial vaginosis.”

2024

November 5th, 2024

The Lund Lab had a small day retreat with snacks, activities, and presentations. 

October 30th, 2024

Sarah Vick presented her work "Decoding mucosal Immunity: Unique natural killer cell profile in vaginal tissue" with Miltenyi Biotec at their Multidimensional Spatial Biology Symposium at fred Hutch Cancer Center. 

October 18th-19th, 2024

Dr. Jenny Lund and her graduate students Lakshmi and Irene presented at their annual UW Pathobiology Retreat at Pack Forest in Eatonville, WA.  

October 18th, 2024

Post-Doc Sarah Vick presented “Decoding mucosal immunity: Unique natural killer cell profile in vaginal tissue” at Fred Hutchinson Cancer Center Postdoctoral Symposium.

October 3rd 2024

Post-Doc Sarah Vick presented at Program in Immunology's Research in Progress Seminar on her work in NK cells: “Tissue NK Cells Balance Host Protection with Tissue Repair”

September 30th, 2024

Finn MacLean presented at Fred Hutch Post-Baccalaureate Scholar Research in Progress on HSV-2 and HIV: "HSV-2 driven vaginal immune alterations and HIV susceptibility"

Spetember 16th-20th, 2024

Fred Hutch finished their Post-Doc Appreciation Week covering our postdoctoral fellow Sarah Vick. Read all about her on the Fred Hutch Linkedin Page. 

July 2024

Check out the Lund Lab's Scientific Spotlight on their new paper. Unique immune profiles in collaborative cross mice linked to survival and viral clearance upon infection. Published in iScience back in March. 

July 6-10, 2024

The Lund Lab went to Society for Mucosal Immunology's International Congress of Mucosal Immunology(ICMI). 

Finn MacLean's talk on Interrogating vaginal immune mechanisms associated with episodes of HSV-2 viral shedding that may promote HIV acquisition. 

Lakshmi's talk on Investigating the impact of type I interferon signaling in regulatory T cells during mucosal HSV-2 infection. 

June 18th, 2024

Finn presented at Fred Hutch Post-Baccalaureate Scholar Program Symposium: "Bacterial vaginosis-driven changes to vaginal T cell phenotypes that may promote HIV susceptibility."

May 15th, 2024

Finn presented at UW Internation Clinical Research Center Work in Progress: "Bacterial vaginosis-driven changes to vaginal T cell phenotypes that may promote HIV susceptibility"

May 3rd-7th, 2024

Sarah presented at the AAI Annual Meeting in Chicago, IL on NK Cells: “Decoding mucosal immunity: Unique natural killer cell profile in vaginal tract”. 

April 26th, 2024

Irene presented at the UW Pathobiology Research Symposium T-cells in mucusoal infection: "Regulatory T cells play a critical role in tuning an appropriate tissue-T cell recall response to mucosal viral infection."

She also, presented the talk earlier this month at the STD/AIDS T32 Annual Retreat. 

March 28th, 2024

Irene presented at Program in Immunology's Research in Progress Seminar on her work in T-Cells: “Regulatory T cells play a critical role in tuning an appropriate tissue-T cell recall response to mucosal viral infection"

March 15th, 2024

Check out our new paper from Jess Graham and Jess Swarts. Unique immune profiles in collaborative cross mice linked to survival and viral clearance upon infection. Published in iScience. Volume. 27, Issue 3. 15 March 2024. 109103

March 14-15th, 2024

Sara presented her talk "High-parameter immune profiling of the female reproductive tract in the context of viral exposure.” at the SouthEast Flow Cytometry Interest Group Meeting in Memphis, TN. 

March 3rd-6th, 2024

Sarah presented a poster at CROI Conference on Retroviruses and Opportunistic Infections:  "CD101 variants are associated with lower levels of genital HIV-inhibiting and tissue repair factors”.